IMMX

10.97

0.46% 0.05

Handel nachbörslich: 10.97

Immix Biopharma Inc (IMMX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$10.92

Offen:

$10.85

24-Stunden-Volumen:

1.30M

Relative Volume:

0.72

Marktkapitalisierung:

$780.95M

Einnahmen:

Nettoeinkommen (Verlust:

$-34.98M

KGV:

-11.93

EPS:

-0.9199

Netto-Cashflow:

$-32.77M

1W Leistung:

+12.86%

1M Leistung:

+2.72%

6M Leistung:

+49.66%

1J Leistung:

+400.91%

1-Tages-Spanne:

$10.36

$11.08

1-Wochen-Bereich:

$9.66

$11.72

52-Wochen-Spanne:

$1.94

$12.14

Immix Biopharma Inc Stock (IMMX) Company Profile

Firmenname

Immix Biopharma Inc

Sektor

Healthcare (1080)

Branche

Biotechnology (604)

Telefon

(888) 958-1084

Adresse

11400 WEST OLYMPIC BLVD., LOS ANGELES

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-14

Neueste SEC-Einreichungen

IMMX's Discussions on Twitter

Compare IMMX vs VRTX, REGN, ARGX, RVMD, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IMMX Immix Biopharma Inc	10.97	809.43M	0	-34.98M	-32.77M	-0.9199
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Immix Biopharma Inc Stock (IMMX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-25	Eingeleitet	Morgan Stanley	Overweight
2026-03-09	Eingeleitet	Citizens	Mkt Outperform
2026-02-09	Eingeleitet	Mizuho	Outperform

Immix Biopharma Inc Aktie (IMMX) Neueste Nachrichten

Aug 14, 2026

Immix Biopharma Stock Price Forecast. Should You Buy IMMX? - StockInvest.us

Aug 14, 2026

Immix Biopharma (NASDAQ:IMMX) Stock Price Down 4.5%Here's Why - marketbeat.com

Aug 14, 2026

Immix Biopharma (IMMX) gains 5.6% stake holder led by Eventide Asset Management - Stock Titan

Aug 14, 2026

Citizens reiterates Immix Biopharma stock rating on pipeline progress - Investing.com

Aug 14, 2026

Citizens reiterates Immix Biopharma stock rating on pipeline progress By Investing.com - Investing.com India

Aug 14, 2026

Morgan Stanley Adjusts PT on Immix Biopharma to $19 From $20, Maintains Overweight Rating - Moomoo

Aug 14, 2026

Aug 13, 2026

Janus Henderson Group (IMMX) discloses 9.78M-share beneficial stake in Immix Biopharma - Stock Titan

Aug 13, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc.IMMX - PR Newswire

Aug 13, 2026

Aug 12, 2026

Immix Biopharma publishes corporate presentation on NXC-201 BCMA CAR-T in relapsed/refractory AL amyloidosis - Bitget

Aug 11, 2026

Immix Biopharma, Inc. Stock 12‑Month Price Target Cut to $20.44, Implies 102% Upside - TradingView

Aug 11, 2026

Immix Biopharma (IMMX) Short Interest & Short Float | Updated Aug 2026 - marketbeat.com

Aug 11, 2026

Aug 10, 2026

IMMIX BIOPHARMA, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $25 FROM $20 - Bitget

Aug 10, 2026

H.C. Wainwright raises Immix Biopharma price target to $25 By Investing.com - Investing.com Australia

Aug 10, 2026

H.C. Wainwright raises Immix Biopharma price target to $25 - Investing.com India

Aug 10, 2026

Regulatory and Data Risks Loom Over Immix Biopharma’s Clinical Programs and Valuation - TipRanks

Aug 10, 2026

Aug 07, 2026

Immix Biopharma (NASDAQ:IMMX) Announces Quarterly Earnings Results - marketbeat.com

Aug 07, 2026

Immix Biopharma (NASDAQ: IMMX) ends Q2 2026 with $232.1M in cash - Stock Titan

Aug 07, 2026

Immix Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 07, 2026

Immix Biopharma (NASDAQ:IMMX) Stock Price Down 6.7%Here's What Happened - marketbeat.com

Aug 07, 2026